Telmisartan Tablets
Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- SPE2D2-24-R-0015
- Agency
- Medical Supply Chain Troop Support, Department of Defense
- Responses due
- Not on record
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
-
- Courtney Hunter-Stangler courtney.hunter-stangler@dla.mil (215) 737-6845
- Jason Wray jason.wray@dla.mil (445) 737-6304
Notice details come from SAM.gov. Updated .
About this opportunity
Paragraph 1:
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Telmisartan Tablets in 20mg, 40mg, and 80mg strengths. This will be an unrestricted and fully competitive commercial item acquisition under FAR Part 12. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. The contract will establish a national supply source to provide the items to Department of Defense, Bureau of Prisons, Indian Health Service, and Department of Veterans Affairs customers through the DLA and VA prime vendor programs. Interested parties are advised to monitor the DLA Bid Board System (DIBBS) and SAM.gov for the solicitation, which is currently projected to be issued in August 2024.
Paragraph 2:
This acquisition will not use any set-aside designations. The agency did not provide any information about potential incumbents or current contractors. The annual usage estimates for the Telmisartan Tablets will be provided in the solicitation's Schedule of Supplies section, but the notice did not include any specifics on potential award values or budget ranges.
Notice text
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for
Telmisartan Tablets. Procurement details follow.
Telmisartan: 20MG, 40MG, and 80MG tablets in 30 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Bureau of Prisons, Indian Health Service and Department of Veterans Affairs customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov at https://sam.gov. Interested parties should contact Courtney Hunter-Stangler at (215) 737-6845 or Courtney.Hunter-Stangler@dla.mil for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is August of 2024. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Telmisartan Tablets | Award Notice | |
| Telmisartan Tablets | Solicitation | |
| Telmisartan Tablets | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity